Characterization of the interaction of ingenol 3-angelate with protein kinase C. - Wikidata - wikimedia - TriplyDB

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

http://www.wikidata.org/entity/Q34547596

about

Observation of Dyakonov Surface Waves Dyakonov Surface Waves in Photonic Metamaterials RasGRPs are targets of the anti-cancer agent ingenol-3-angelate Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers Oxidation and cyclization of casbene in the biosynthesis of Euphorbia factors from mature seeds of Euphorbia lathyris L Effects of αTAT1 and HDAC5 on axonal regeneration in adult neurons.Tattoo removal with ingenol mebutate.Euphohelioscopin A is a PKC activator capable of inducing macrophage differentiation.The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.Charge density influences C1 domain ligand affinity and membrane interactions Controlling the Mdm2-Mdmx-p53 Circuit.Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.A historical overview of natural products in drug discovery.Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.Up-regulation of anti-apoptotic genes confers resistance to the novel anti-leukaemic compound PEP005 in primary AML cells Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.Ablative fractional laser alters biodistribution of ingenol mebutate in the skin.Drug discovery from natural sources.Enzymatic chemistry of cyclopropane, epoxide, and aziridine biosynthesis.Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice.New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.Digging deep into "dirty" drugs - modulation of the methylation machinery.Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.The therapeutic role of targeting protein kinase C in solid and hematologic malignancies.Evolutionary prediction of medicinal properties in the genus Euphorbia L.Ingenol Protects Human T Cells From HIV-1 Infection.Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis.Injury-induced HDAC5 nuclear export is essential for axon regeneration.Evaluation of the skin sensitization, photoirritation, and photoallergic potential of ingenol mebutate gel in healthy volunteers.Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis.Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers.Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate Ingenane Diterpenoids.The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity

P2860

Q27335701-A6C85677-918D-4E49-9328-459D957017C7 Q27350012-E6CB29B7-6095-4372-86ED-A475942EACDF Q28535474-9AA478C4-152C-48B2-A895-8F71F24D5440 Q28820706-1E1FC56C-F3CB-41D7-9FDE-DBF844679139 Q28828621-E6FA9E42-AFD5-4094-A6A0-7E204852B3E7 Q33688273-D9F52C36-CAD8-4B90-93C1-77355D34AC26 Q33739024-6BF3D937-FFCD-49EF-8FCC-6EE5CBA6DFBD Q33838264-A0141EEF-9949-4120-BDCD-2853C6C43A2F Q33891947-C209E776-27CC-4422-8D26-2BFC8C7CFEB2 Q33959125-637A8A00-6BD7-4F55-8D14-34B2E0E1E9E9 Q34011009-EB6940E5-7CB0-4568-8991-4B577FFBBA07 Q34299210-59FE8B22-1A10-41A2-90FC-88D43636ED1C Q34426191-DE0D9703-2049-4695-8321-F86CDE86D0F7 Q34600909-38F970FE-26AC-4D9B-8A38-19ABE8C5322A Q34781362-5C0C6142-226F-4FC6-AEED-F309411169B9 Q35168379-C62982AA-A47D-44B5-AAAA-355256F76448 Q35592491-F45EB113-80E8-411B-9E81-BBD5F3EED3F9 Q35594873-D8945ACA-3A22-4B41-916D-C5E2C87AF0EE Q35785144-144AB351-D5D7-4A56-B5B7-3E904FD86B5F Q35856396-D944A4CE-9DDD-455C-B774-5B3292FD7BF6 Q35996041-EECA55B0-A085-49E0-813A-97C7E7B8254B Q36128569-9AEB6776-A21F-487A-AB2A-18D69E020762 Q36135774-647F1B92-BEFF-463C-8C32-BF0DCF1BB0E3 Q36196699-8ED88296-5AAC-4969-A778-01755E130763 Q36523796-84746474-2F27-4A4B-A0EC-17FB2AA0C846 Q36781257-89F204E0-3288-4F63-9EE5-03C904574930 Q36964732-9FC2513A-EA97-4868-96E1-D0FB88EAE493 Q37134190-9DD03B14-018D-4E5A-B7FD-F5A26B10EBCE Q37155721-272A3728-470A-449A-8674-63E3BACDD12D Q37646770-0645E51D-E6C8-4DED-96C0-D45AA48944D6 Q37704511-AE2BE04C-2953-4BC2-863C-E6DBBC92D4EA Q37708878-B3AA770E-6DD5-481E-9156-6F6FE020C33F Q38066531-00051DA8-288F-442A-B3F2-3DB45D4203DE Q38106805-56EC1E3C-3A06-4B12-AF3F-C951A87B1C3C Q38156717-1D5AD7C1-9216-44E1-86A9-46221F82BF7D Q38546598-974F7F6B-7F81-492C-858D-E4FE0EE27D9C Q38622474-F18568D0-69A1-45D7-A08E-5D8CC93185F7 Q38750781-E874F46C-B447-4A83-859B-FB297577DCB9 Q38886766-40A4D0A7-8E03-4B59-AE46-CE5B4D921962 Q38913840-FDCED406-C46E-4C7F-94EB-99FC4CC5E8A9

P2860

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

http://www.wikidata.org/entity/Q34547596

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@ast

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@en

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@nl

type

label

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@ast

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@en

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@nl

prefLabel

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@ast

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@en

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@nl

P1433

Q34547596-BA986DC2-B31A-46F8-AA10-8F86A99730AB

P1476

Q34547596-4D0EAE61-6691-4A14-945F-5BA7A4660B9F

P2093

Q34547596-2AA72B6D-8C41-4BC9-AEE0-74529FE37107

Q34547596-418EB64A-F0F2-478C-9BC2-D6038117E0F8

Q34547596-4BF6E9EC-B632-4079-9778-19C008F9CBCE

Q34547596-CA1C898B-9EFB-4ED0-8E64-B95ECAAE5C52

Q34547596-F1ABB6C5-F83E-4ED8-B075-DACB05A7DDB8

Q34547596-F2E09427-9C82-4562-B825-5956E28212F8

P304

Q34547596-755460B5-5376-44B7-9947-EEAEB59D0F1A

P31

Q34547596-FFD7014B-44C3-4495-8148-B713AE19BDDC

P356

Q34547596-D24E4E3F-F515-4157-89E8-867D4B346E14

P407

Q34547596-2631AE92-2EC1-44E3-B134-95ADC3EA48F9

P433

Q34547596-27B610AD-4ECE-4CE5-BD82-AD086DBF7E82

P478

Q34547596-0E8F7AFE-FDC6-433C-BD39-C6997D0F3147

P577

Q34547596-D0516DE0-8D2D-4FF8-A2E1-108A15D03147

P5875

Q34547596-DAA63983-95A7-4C96-8E81-76075805A555

P698

Q34547596-4397852D-69C5-4A64-9113-53BD115B21EB

P356

0008-5472.CAN-03-3403

P1433

Cancer Research

P1476

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

@en

P2093

Attila Toth

http://www.w3.org/2001/XMLSchema#string

Daniel J Lundberg

http://www.w3.org/2001/XMLSchema#string

Noemi Kedei

http://www.w3.org/2001/XMLSchema#string

Peter M Blumberg

http://www.w3.org/2001/XMLSchema#string

Peter Welburn

http://www.w3.org/2001/XMLSchema#string

Susan H Garfield

http://www.w3.org/2001/XMLSchema#string

P304

3243-3255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-03-3403

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273600704

http://www.w3.org/2001/XMLSchema#string

P698

15126366

http://www.w3.org/2001/XMLSchema#string